Zantac Litigation Update: Latest Developments

The mass action litigation against the makers of the popular antacid medication Zantac is still in the early stages. On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued an immediate market withdrawal request of all ranitidine-based medications including Zantac.